Annual SG&A
$0.00$41.61B-100.00%
Summary
- Current Value
- As of today, CVS annual SG&A is $0.00, down -100.00% on
- Historical Performance
- CVS annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
- All-Time High Comparison
- CVS annual SG&A is currently -100.00% below its historical high of $41.61B set on
- Sector Comparison
- CVS annual SG&A is higher than 72.89% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $11.05B | -1.5% | +11.9% | +24.6% | +206.4% | |
| TTM SG&A | $248.98B | +474.9% | +535.9% | +597.5% | +1643.5% | |
| Price | $94.08 | +32.6% | +40.8% | +11.7% | +190.6% | |
| Annual Operating Expenses | $44.98B | +8.7% | +17.7% | +28.2% | +219.2% | |
| Annual Operating Profit | $10.39B | +4.7% | -37.5% | -25.4% | +68.5% | |
| Annual D&A | $4.61B | +0.2% | +9.0% | +3.7% | +213.6% | |
| Annual Revenue | $402.11B | +7.9% | +24.6% | +49.7% | +317.1% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $41.61B | -100.0% | |
| 5Y | $41.61B | -100.0% | |
| All | $41.61B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
- What is the current annual SG&A of CVS?
- As of today, CVS annual SG&A is $0.00
- What is 1-year change in CVS annual SG&A?
- CVS annual SG&A is down -100.00% year-over-year
- What is 3-year change in CVS annual SG&A?
- CVS annual SG&A is down -100.00% over the past 3 years
- How far is CVS annual SG&A from its all-time high?
- CVS annual SG&A is currently -100.00% below its historical high of $41.61B set on December 31, 2024
- How does CVS annual SG&A rank versus sector peers?
- CVS annual SG&A is higher than 72.89% of companies in Healthcare sector
- When is CVS next annual earnings release?
- As of today, the next annual earnings release for CVS has not been scheduled
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Quarterly SG&A
$11.05B$102.00M+0.93%
Summary
- Current Value
- As of today, CVS quarterly SG&A is $11.05B, up +0.93% on
- Historical Performance
- CVS quarterly SG&A is down -1.48% year-over-year, up +11.88% over the past 3 years
- All-Time High Comparison
- CVS quarterly SG&A is currently -3.57% below its historical high of $11.46B set on
- 3-Year Low Comparison
- CVS quarterly SG&A is +11.88% above its 3-year low of $9.87B reached on an earlier date
- Sector Comparison
- CVS quarterly SG&A is higher than 100.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $11.05B | +0.9% | -1.5% | +11.9% | +24.6% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $248.98B | +454.5% | +474.9% | +535.9% | +597.5% | |
| Price | $94.08 | -0.1% | +32.6% | +40.8% | +11.7% | |
| Quarterly Operating Expenses | $11.04B | +0.9% | +7.1% | +13.6% | +25.0% | |
| Quarterly Operating Profit | $4.73B | +0.4% | +42.6% | +18.6% | +8.6% | |
| Quarterly D&A | $1.13B | +1.0% | -3.8% | +2.0% | -1.0% | |
| Quarterly Revenue | $106.11B | +5.6% | +7.2% | +19.2% | +46.1% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.46B | -3.6% | |
| 3Y | $11.46B | -3.6% | |
| 5Y | $11.46B | -3.6% | |
| All | $11.46B | -3.6% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $10.94B | +0.9% | |
| 3Y | $9.87B | N/A | +11.9% |
| 5Y | $8.87B | N/A | +24.6% |
| All | -$275.90M | +4103.6% |
Quarterly SG&A History
FAQ
- What is the current quarterly SG&A of CVS?
- As of today, CVS quarterly SG&A is $11.05B
- What is CVS quarterly SG&A most recent change?
- CVS quarterly SG&A was up +0.93% on June 30, 2026
- What is 1-year change in CVS quarterly SG&A?
- CVS quarterly SG&A is down -1.48% year-over-year
- How far is CVS quarterly SG&A from its all-time high?
- CVS quarterly SG&A is currently -3.57% below its historical high of $11.46B set on December 31, 2025
- How does CVS quarterly SG&A rank versus sector peers?
- CVS quarterly SG&A is higher than 100.00% of companies in Healthcare sector
- When is CVS next earnings release?
- The next earnings release for CVS is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
TTM SG&A
$248.98B$1.46B+0.59%
Summary
- Current Value
- As of today, CVS TTM SG&A is $248.98B, up +0.59% on
- Historical Performance
- CVS TTM SG&A is up +474.86% year-over-year, up +535.91% over the past 3 years
- All-Time High Comparison
- CVS TTM SG&A is currently -1.42% below its historical high of $252.58B set on an earlier date
- 3-Year Low Comparison
- CVS TTM SG&A is +9.40% above its 3-year low of $227.59B reached on an earlier date
- Sector Comparison
- CVS TTM SG&A is higher than 99.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $248.98B | +454.5% | +474.9% | +535.9% | +597.5% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $11.05B | +0.9% | -1.5% | +11.9% | +24.6% | |
| Price | $94.08 | -0.1% | +32.6% | +40.8% | +11.7% | |
| TTM Operating Profit | $14.71B | +10.6% | +26.6% | -5.9% | +5.8% | |
| TTM D&A | $4.52B | -1.0% | -2.4% | +7.7% | +0.1% | |
| TTM Revenue | $415.11B | +1.8% | +7.4% | +22.3% | +49.2% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $252.58B | N/A | -1.4% |
| 3Y | $252.58B | N/A | -1.4% |
| 5Y | $252.58B | N/A | -1.4% |
| All | $252.58B | N/A | -1.4% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $247.52B | N/A | +0.6% |
| 3Y | $227.59B | N/A | +9.4% |
| 5Y | $203.50B | N/A | +22.4% |
| All | $873.70M | N/A | >+9999.0% |
TTM SG&A History
FAQ
- What is the current TTM SG&A of CVS?
- As of today, CVS TTM SG&A is $248.98B
- What is CVS TTM SG&A most recent change?
- CVS TTM SG&A was up +0.59% on June 30, 2026
- What is 1-year change in CVS TTM SG&A?
- CVS TTM SG&A is up +474.86% year-over-year
- How does CVS TTM SG&A rank versus sector peers?
- CVS TTM SG&A is higher than 99.73% of companies in Healthcare sector
- When is CVS next earnings release?
- The next earnings release for CVS is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- CVS Official Website www.cvshealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm
- CVS Profile on Yahoo Finance finance.yahoo.com/quote/CVS
- CVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cvs
